Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 161 entries
Sorted by: Best Match Show Resources per page
Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.

Journal of diabetes investigation

Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y.
PMID: 28921915
J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16.

AIMS/INTRODUCTION: The present phase 3, randomized, double-blind 24-week study with extension to 1 year assessed the efficacy and safety of albiglutide compared with placebo in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet and exercise with...

Cite
Nino A, Okuda I, Wilson TH, et al. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017;doi: 10.1111/jdi.12749.
Nino, A., Okuda, I., Wilson, T. H., Yue, L., Nakajima, H., Tsuboi, M., Carr, M. C., & Seino, Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Journal of diabetes investigation, . https://doi.org/10.1111/jdi.12749
Nino, Antonio, et al. "Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study." Journal of diabetes investigation vol. (2017). doi: https://doi.org/10.1111/jdi.12749
Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16. PMID: 28921915; PMCID: PMC5934244.
Copy Download .nbib Format: NLM
Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures.

Beilstein journal of organic chemistry

Trollope L, Cruickshank DL, Noonan T, Bourne SA, Sorrenti M, Catenacci L, Caira MR.
PMID: 25670983
Beilstein J Org Chem. 2014 Dec 29;10:3136-51. doi: 10.3762/bjoc.10.331. eCollection 2014.

The phytoalexin trans-resveratrol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, is a well-known, potent antioxidant having a variety of possible biomedical applications. However, its adverse physicochemical properties (low stability, poor aqueous solubility) limit such applications and its inclusion in cyclodextrins (CDs) has potential for addressing...

Cite
Trollope L, Cruickshank DL, Noonan T, et al. Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures. Beilstein J Org Chem. 2014;10:3136-51doi: 10.3762/bjoc.10.331.
Trollope, L., Cruickshank, D. L., Noonan, T., Bourne, S. A., Sorrenti, M., Catenacci, L., & Caira, M. R. (2014). Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures. Beilstein journal of organic chemistry, 103136-51. https://doi.org/10.3762/bjoc.10.331
Trollope, Lee, et al. "Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures." Beilstein journal of organic chemistry vol. 10 (2014): 3136-51. doi: https://doi.org/10.3762/bjoc.10.331
Trollope L, Cruickshank DL, Noonan T, Bourne SA, Sorrenti M, Catenacci L, Caira MR. Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures. Beilstein J Org Chem. 2014 Dec 29;10:3136-51. doi: 10.3762/bjoc.10.331. eCollection 2014. PMID: 25670983; PMCID: PMC4311586.
Copy Download .nbib Format: NLM
The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts.

Nitric oxide : biology and chemistry

Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC.
PMID: 26241941
Nitric Oxide. 2015 Nov 15;50:10-19. doi: 10.1016/j.niox.2015.07.004. Epub 2015 Aug 01.

The myocardial response to mechanical stretch (Frank-Starling law) is an important physiological cardiac determinant. Modulated by many endogenous substances, it is impaired in the presence of cardiovascular pathologies and during senescence. Catestatin (CST:hCgA352-372), a 21-amino-acid derivate of Chromogranin A...

Cite
Angelone T, Quintieri AM, Pasqua T, et al. The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide. 2015;50:10-19doi: 10.1016/j.niox.2015.07.004.
Angelone, T., Quintieri, A. M., Pasqua, T., Filice, E., Cantafio, P., Scavello, F., Rocca, C., Mahata, S. K., Gattuso, A., & Cerra, M. C. (2015). The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric oxide : biology and chemistry, 5010-19. https://doi.org/10.1016/j.niox.2015.07.004
Angelone, T, et al. "The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts." Nitric oxide : biology and chemistry vol. 50 (2015): 10-19. doi: https://doi.org/10.1016/j.niox.2015.07.004
Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC. The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide. 2015 Nov 15;50:10-19. doi: 10.1016/j.niox.2015.07.004. Epub 2015 Aug 01. PMID: 26241941.
Copy Download .nbib Format: NLM
Experience with long-term rituximab use in a multiple sclerosis clinic.

Multiple sclerosis journal - experimental, translational and clinical

Barra ME, Soni D, Vo KH, Chitnis T, Stankiewicz JM.
PMID: 28607739
Mult Scler J Exp Transl Clin. 2016 Oct 09;2:2055217316672100. doi: 10.1177/2055217316672100. eCollection 2016.

BACKGROUND: Rituximab is a monoclonal antibody directed at CD20 positive B-lymphocytes and a potential therapeutic option in the treatment of multiple sclerosis. The safety of recurrent dosing is not established.OBJECTIVES: The objective of this work was to report the...

Cite
Barra ME, Soni D, Vo KH, et al. Experience with long-term rituximab use in a multiple sclerosis clinic. Mult Scler J Exp Transl Clin. 2016;2:2055217316672100doi: 10.1177/2055217316672100.
Barra, M. E., Soni, D., Vo, K. H., Chitnis, T., & Stankiewicz, J. M. (2016). Experience with long-term rituximab use in a multiple sclerosis clinic. Multiple sclerosis journal - experimental, translational and clinical, 22055217316672100. https://doi.org/10.1177/2055217316672100
Barra, Megan E, et al. "Experience with long-term rituximab use in a multiple sclerosis clinic." Multiple sclerosis journal - experimental, translational and clinical vol. 2 (2016): 2055217316672100. doi: https://doi.org/10.1177/2055217316672100
Barra ME, Soni D, Vo KH, Chitnis T, Stankiewicz JM. Experience with long-term rituximab use in a multiple sclerosis clinic. Mult Scler J Exp Transl Clin. 2016 Oct 09;2:2055217316672100. doi: 10.1177/2055217316672100. eCollection 2016. PMID: 28607739; PMCID: PMC5433395.
Copy Download .nbib Format: NLM
Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: Steady-state fluorescence polarization and phase fluorometry studies.

Journal of fluorescence

Miccoli L, Szczepaniak C, Dumas D, Savonnière S, Muller S, Carré MC, Donner M.
PMID: 24234905
J Fluoresc. 1993 Dec;3(4):251-5. doi: 10.1007/BF00865273.

The potential interest of DPH-PC was checked with a macrophagic cell line (P388D1). The uptake of DPH-PC was associated with a rapid increase in both fluorescence intensity and a slow decrease in anisotropy values. A flow cytometry comparative study...

Cite
Miccoli L, Szczepaniak C, Dumas D, et al. Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: Steady-state fluorescence polarization and phase fluorometry studies. J Fluoresc. 1993;3(4):251-5doi: 10.1007/BF00865273.
Miccoli, L., Szczepaniak, C., Dumas, D., Savonnière, S., Muller, S., Carré, M. C., & Donner, M. (1993). Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: Steady-state fluorescence polarization and phase fluorometry studies. Journal of fluorescence, 3(4), 251-5. https://doi.org/10.1007/BF00865273
Miccoli, L, et al. "Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: Steady-state fluorescence polarization and phase fluorometry studies." Journal of fluorescence vol. 3,4 (1993): 251-5. doi: https://doi.org/10.1007/BF00865273
Miccoli L, Szczepaniak C, Dumas D, Savonnière S, Muller S, Carré MC, Donner M. Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: Steady-state fluorescence polarization and phase fluorometry studies. J Fluoresc. 1993 Dec;3(4):251-5. doi: 10.1007/BF00865273. PMID: 24234905.
Copy Download .nbib Format: NLM
[Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication].

Revista colombiana de psiquiatria

de la Espriella Guerrero R, de la Hoz Bradford AM, Zárate AU, Lee PR, Menéndez MC, Rentería AM, Hernández DC, Cardeño C, Barré MC, Kunzel GH, Gómez-Restrepo C.
PMID: 26572267
Rev Colomb Psiquiatr. 2012 Dec;41(4):805-25. doi: 10.1016/S0034-7450(14)60048-2. Epub 2014 May 10.

INTRODUCTION: Worldwide, alcohol is the second most-used psychotropic substance and the third risk factor for early death and disability. Its noxious use is a world public health problem given its personal, labor, family, economic and social impact. The identification...

Cite
de la Espriella Guerrero R, de la Hoz Bradford AM, Zárate AU, et al. Guía de práctica clínica para la detección temprana, diagnóstico y tratamiento de la fase aguda de intoxicación de pacientes con abuso o dependencia del alcohol: Parte II: Evaluación y manejo de los pacientes con intoxicación aguda por alcohol. [Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication]. Rev Colomb Psiquiatr. 2014;41(4):805-25doi: 10.1016/S0034-7450(14)60048-2.
de la Espriella Guerrero, R., de la Hoz Bradford, A. M., Zárate, A. U., Lee, P. R., Menéndez, M. C., Rentería, A. M., Hernández, D. C., Cardeño, C., Barré, M. C., Kunzel, G. H., & Gómez-Restrepo, C. (2012). Guía de práctica clínica para la detección temprana, diagnóstico y tratamiento de la fase aguda de intoxicación de pacientes con abuso o dependencia del alcohol: Parte II: Evaluación y manejo de los pacientes con intoxicación aguda por alcohol. [Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication]. Revista colombiana de psiquiatria, 41(4), 805-25. https://doi.org/10.1016/S0034-7450(14)60048-2
de la Espriella Guerrero, Ricardo, et al. "Guía de práctica clínica para la detección temprana, diagnóstico y tratamiento de la fase aguda de intoxicación de pacientes con abuso o dependencia del alcohol: Parte II: Evaluación y manejo de los pacientes con intoxicación aguda por alcohol." [Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication]. Revista colombiana de psiquiatria vol. 41,4 (2012): 805-25. doi: https://doi.org/10.1016/S0034-7450(14)60048-2
de la Espriella Guerrero R, de la Hoz Bradford AM, Zárate AU, Lee PR, Menéndez MC, Rentería AM, Hernández DC, Cardeño C, Barré MC, Kunzel GH, Gómez-Restrepo C. Guía de práctica clínica para la detección temprana, diagnóstico y tratamiento de la fase aguda de intoxicación de pacientes con abuso o dependencia del alcohol: Parte II: Evaluación y manejo de los pacientes con intoxicación aguda por alcohol. [Clinical Practice Guide for Early Detection, Diagnosis and Treatment of the Acute Intoxication Phase in Patients with Alcohol Abuse or Dependence: Part II: Evaluation and Management of Patients with Acute Alcohol Intoxication]. Rev Colomb Psiquiatr. 2012 Dec;41(4):805-25. doi: 10.1016/S0034-7450(14)60048-2. Epub 2014 May 10. Spanish. PMID: 26572267.
Copy Download .nbib Format: NLM
An Evaluation of Systemic Vancomycin Dosing in Obese Patients.

Open forum infectious diseases

Kubiak DW, Alquwaizani M, Sansonetti D, Barra ME, Calderwood MS.
PMID: 26716105
Open Forum Infect Dis. 2015 Nov 13;2(4):ofv176. doi: 10.1093/ofid/ofv176. eCollection 2015 Dec.

We retrospectively identified 67 patients with severe or morbid obesity (body mass index ≥35 kg/m(2)) who had received intravenous vancomycin at our institution. We observed that an initial dose of 45 to 65 mg/kg vancomycin per day based upon...

Cite
Kubiak DW, Alquwaizani M, Sansonetti D, et al. An Evaluation of Systemic Vancomycin Dosing in Obese Patients. Open Forum Infect Dis. 2015;2(4):ofv176doi: 10.1093/ofid/ofv176.
Kubiak, D. W., Alquwaizani, M., Sansonetti, D., Barra, M. E., & Calderwood, M. S. (2015). An Evaluation of Systemic Vancomycin Dosing in Obese Patients. Open forum infectious diseases, 2(4), ofv176. https://doi.org/10.1093/ofid/ofv176
Kubiak, David W, et al. "An Evaluation of Systemic Vancomycin Dosing in Obese Patients." Open forum infectious diseases vol. 2,4 (2015): ofv176. doi: https://doi.org/10.1093/ofid/ofv176
Kubiak DW, Alquwaizani M, Sansonetti D, Barra ME, Calderwood MS. An Evaluation of Systemic Vancomycin Dosing in Obese Patients. Open Forum Infect Dis. 2015 Nov 13;2(4):ofv176. doi: 10.1093/ofid/ofv176. eCollection 2015 Dec. PMID: 26716105; PMCID: PMC4691676.
Copy Download .nbib Format: NLM
[No title available]

International orthodontics

Saulue P, Carra MC, Laluque JF, d'Incau E.
PMID: 26608468
Int Orthod. 2015 Oct 22; doi: 10.1016/j.ortho.2015.09.002. Epub 2015 Oct 22.

No abstract available.

Cite
Saulue P, Carra MC, Laluque JF, et al. Comprendre les bruxismes chez l'enfant et l'adolescent. . Int Orthod. 2015;doi: 10.1016/j.ortho.2015.09.002.
Saulue, P., Carra, M. C., Laluque, J. F., & d'Incau, E. (2015). Comprendre les bruxismes chez l'enfant et l'adolescent. . International orthodontics, . https://doi.org/10.1016/j.ortho.2015.09.002
Saulue, Paul, et al. "Comprendre les bruxismes chez l'enfant et l'adolescent." . International orthodontics vol. (2015). doi: https://doi.org/10.1016/j.ortho.2015.09.002
Saulue P, Carra MC, Laluque JF, d'Incau E. Comprendre les bruxismes chez l'enfant et l'adolescent. . Int Orthod. 2015 Oct 22; doi: 10.1016/j.ortho.2015.09.002. Epub 2015 Oct 22. French. PMID: 26608468.
Copy Download .nbib Format: NLM
Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction.

Beilstein journal of organic chemistry

Caira MR, Bourne SA, Samsodien H, Smith VJ.
PMID: 26734107
Beilstein J Org Chem. 2015 Dec 16;11:2616-30. doi: 10.3762/bjoc.11.281. eCollection 2015.

The interaction between the potent anticancer agent 2-methoxyestradiol (2ME) and a series of cyclodextrins (CDs) was investigated in the solid state using thermal analysis and X-ray diffraction, while the possibility of enhancing its poor aqueous solubility with CDs was...

Cite
Caira MR, Bourne SA, Samsodien H, et al. Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction. Beilstein J Org Chem. 2015;11:2616-30doi: 10.3762/bjoc.11.281.
Caira, M. R., Bourne, S. A., Samsodien, H., & Smith, V. J. (2015). Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction. Beilstein journal of organic chemistry, 112616-30. https://doi.org/10.3762/bjoc.11.281
Caira, Mino R, et al. "Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction." Beilstein journal of organic chemistry vol. 11 (2015): 2616-30. doi: https://doi.org/10.3762/bjoc.11.281
Caira MR, Bourne SA, Samsodien H, Smith VJ. Inclusion complexes of 2-methoxyestradiol with dimethylated and permethylated β-cyclodextrins: models for cyclodextrin-steroid interaction. Beilstein J Org Chem. 2015 Dec 16;11:2616-30. doi: 10.3762/bjoc.11.281. eCollection 2015. PMID: 26734107; PMCID: PMC4685897.
Copy Download .nbib Format: NLM
Random bond XXZ chains with modulated couplings.

Physical review letters

Cabra DC, De Martino A, Grynberg MD, Peysson S, Pujol P.
PMID: 11082653
Phys Rev Lett. 2000 Nov 27;85(22):4791-4. doi: 10.1103/PhysRevLett.85.4791.

The magnetization behavior of q-periodic antiferromagnetic spin- 1/2 Heisenberg chains under uniform magnetic fields is investigated in a background of disorder exchange distributions. By means of both real space decimation procedures and numerical diagonalizations in XX chains, it is...

Cite
Cabra DC, De Martino A, Grynberg MD, et al. Random bond XXZ chains with modulated couplings. Phys Rev Lett. 2000;85(22):4791-4doi: 10.1103/PhysRevLett.85.4791.
Cabra, D. C., De Martino A, Grynberg, M. D., Peysson, S., & Pujol, P. (2000). Random bond XXZ chains with modulated couplings. Physical review letters, 85(22), 4791-4. https://doi.org/10.1103/PhysRevLett.85.4791
Cabra, et al. "Random bond XXZ chains with modulated couplings." Physical review letters vol. 85,22 (2000): 4791-4. doi: https://doi.org/10.1103/PhysRevLett.85.4791
Cabra DC, De Martino A, Grynberg MD, Peysson S, Pujol P. Random bond XXZ chains with modulated couplings. Phys Rev Lett. 2000 Nov 27;85(22):4791-4. doi: 10.1103/PhysRevLett.85.4791. PMID: 11082653.
Copy Download .nbib Format: NLM
Tunable clathrates.

Chemical communications (Cambridge, England)

Caira MR, le Roex T, Nassimbeni LR.
PMID: 12240196
Chem Commun (Camb). 2001 Oct 21;(20):2128-9. doi: 10.1039/b106080p.

Investigation of the selectivity of a diol organic host for mixtures of DMF and DMSO, showed the formation of five inclusion compounds in which the stoichiometry varies in discrete steps and is determined by the composition of the liquid...

Cite
Caira MR, le Roex T, Nassimbeni LR. Tunable clathrates. Chem Commun (Camb). 2001;(20):2128-9doi: 10.1039/b106080p.
Caira, M. R., le Roex, T., & Nassimbeni, L. R. (2001). Tunable clathrates. Chemical communications (Cambridge, England), (20), 2128-9. https://doi.org/10.1039/b106080p
Caira, M R, et al. "Tunable clathrates." Chemical communications (Cambridge, England) vol. ,20 (2001): 2128-9. doi: https://doi.org/10.1039/b106080p
Caira MR, le Roex T, Nassimbeni LR. Tunable clathrates. Chem Commun (Camb). 2001 Oct 21;(20):2128-9. doi: 10.1039/b106080p. PMID: 12240196.
Copy Download .nbib Format: NLM
Diruthenium(II,III) Carboxylate Compounds: Existence of both Polymeric and Ionic Forms in Solution and Solid State.

Inorganic chemistry

Barral MC, Jiménez-Aparicio R, Priego JL, Royer EC, Urbanos FA, Amador U.
PMID: 11670354
Inorg Chem. 1998 Mar 23;37(6):1413-1416. doi: 10.1021/ic9708024.

No abstract available.

Cite
Barral MC, Jiménez-Aparicio R, Priego JL, et al. Diruthenium(II,III) Carboxylate Compounds: Existence of both Polymeric and Ionic Forms in Solution and Solid State. Inorg Chem. 1998;37(6):1413-1416doi: 10.1021/ic9708024.
Barral, M. C., Jiménez-Aparicio, R., Priego, J. L., Royer, E. C., Urbanos, F. A., & Amador, U. (1998). Diruthenium(II,III) Carboxylate Compounds: Existence of both Polymeric and Ionic Forms in Solution and Solid State. Inorganic chemistry, 37(6), 1413-1416. https://doi.org/10.1021/ic9708024
Barral, M. Carmen, et al. "Diruthenium(II,III) Carboxylate Compounds: Existence of both Polymeric and Ionic Forms in Solution and Solid State." Inorganic chemistry vol. 37,6 (1998): 1413-1416. doi: https://doi.org/10.1021/ic9708024
Barral MC, Jiménez-Aparicio R, Priego JL, Royer EC, Urbanos FA, Amador U. Diruthenium(II,III) Carboxylate Compounds: Existence of both Polymeric and Ionic Forms in Solution and Solid State. Inorg Chem. 1998 Mar 23;37(6):1413-1416. doi: 10.1021/ic9708024. PMID: 11670354.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 161 entries